Target intelligence / Profile preview

Solute Carrier Family 7 Member 11 (SLC7A11)

Target
SLC7A11
Molecular classification
Transporter, Solute Carrier
01

Overview

SLC7A11, also known as xCT, is a protein that functions as the light chain subunit of system Xc-, a sodium-independent cystine/glutamate antiporter. It imports extracellular cystine into cells in exchange for exporting intracellular glutamate. Cystine is then reduced to cysteine, a precursor for glutathione (GSH) synthesis, which protects cells from oxidative stress and ferroptosis. SLC7A11 is highly expressed in cancer cells, where it promotes tumor growth by enhancing antioxidant capacity. It is also involved in neurological disorders due to its role in glutamate release. SLC7A11 is regulated by transcriptional factors like NRF2 and p53, as well as epigenetic and post-translational mechanisms.

Other names
xCTCystine/Glutamate TransporterAmino Acid Transport System Xc-Calcium Channel Blocker Resistance Protein CCBR1Solute Carrier Family 7 (Anionic Amino Acid Transporter Light Chain, Xc- System), Member 11
02

Mechanism of action

Inhibition of cystine/glutamate antiporter activity, leading to decreased glutathione synthesis and increased oxidative stress.

03

Biological functions

Cystine transportGlutamate transportGlutathione biosynthesisRedox homeostasisCell proliferation
04

Disease associations

CancerCystinuriaLysinuric protein intoleranceNeurological disordersEpilepsyNeurodegeneration
05

Safety considerations

Potential for neuronal toxicity due to excessive glutamate releaseOff-target effects of inhibitors on other solute carriers
06

Biomarkers

SLC7A11 expression levels in tumor tissue

Beyond the preview

Go deeper on Solute Carrier Family 7 Member 11 (SLC7A11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute Carrier Family 7 Member 11 (SLC7A11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call